28 November 2017 1 Min Read
PHARMACEUTICALS
Cancer drug the first biosimilar to get local go-ahead
Cancer treatment advocates say the decision will boost competition and drive down prices
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In